Doug Coyle is a health economist and Professor in both the Health Economics Research Group at Brunel University and the Department of Epidemiology and Community Medicine at the University of Ottawa. Doug obtained his PhD from Brunel University. He was previously based at the Ottawa Hospital Research Institute and the Centre for Health Economics at the University of York.Doug has taught graduate courses in health economics for the past eighteen years and has supervised many MSc and PhD students.
Newest selected publications
Tricco, AC., Lachance, CC., Rios, P., Darvesh, N., Antony, J., Radhakrishnan, A., (2020) 'Global evidence of gender inequity in academic health research: A living scoping review protocol'. JBI Evidence Synthesis, 18 (10). pp. 2181 - 2193. ISSN: 2689-8381et al.
Thavorn, K., Van Katwyk, S., Krahn, M., Mei, SHJ., Stewart, DJ., Fergusson, D., (2020) 'Value of mesenchymal stem cell therapy for patients with septic shock: An early health economic evaluation'. International Journal of Technology Assessment in Health Care, 36 (5). pp. 525 - 532. ISSN: 0266-4623et al.
Thavorn, K., Coyle, D., Hoch, JS., Vandermeer, L., Mazzarello, S., Wang, Z., (2017) 'A cost-utility analysis of risk model-guided versus physician’s choice antiemetic prophylaxis in patients receiving chemotherapy for early-stage breast cancer: a net benefit regression approach'. Supportive Care in Cancer, 25 (8). pp. 2505 - 2513. ISSN: 0941-4355 Open Access Linket al.
Coyle, D., Ko, YJ., Coyle, K., Saluja, R., Shah, K., Lien, K., (2017) 'Cost-Effectiveness Analysis of Systemic Therapies in Advanced Pancreatic Cancer in the Canadian Health Care System'. Value in Health, 20 (4). pp. 586 - 592. ISSN: 1098-3015 Open Access Linket al.
Coyle, D. (2017) 'Increasing the methodological quality and relevance of cost effectiveness analysis'. Thrombosis Research, 150. pp. 121 - 122. ISSN: 0049-3848 Open Access Link